Tembexa Tablet, Film Coated
Product Images NDC 64678-010

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tembexa (NDC 64678-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biodefense Operations Lansing Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of brincidofovir shown as a molecular diagram with labeled functional groups including amine, phosphate, and long alkyl side chain components.*

FDA Label Image

Blister Carton Label (Image 02)

The packaging label for Tembexa film-coated tablets displays the proprietary name Tembexa and generic name brincidofovir. It indicates 100 mg per tablet oral dosage form, with a count of 4 tablets. The labeler is Emergent BioDefense Operations Lansing LLC. Instructions for opening the container and storage conditions are also included along with the product NDC 64678-0101.*

FDA Label Image

Blister Pack Label (Image 03)

Tembexa (brincidofovir) 100 mg film-coated oral tablets full blister card showing four tablets. The label includes the product name, active ingredient, strength, NDC 64678-010-01, and manufacturer Emergent BioDefense Operations Lansing LLC. The card also has marked spaces for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.